Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $4.24 Million - $5.48 Million
-23,400 Reduced 56.66%
17,900 $3.43 Million
Q4 2021

Feb 11, 2022

BUY
$193.69 - $247.03 $1.82 Million - $2.32 Million
9,400 Added 29.47%
41,300 $10.1 Million
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $1.29 Million - $1.43 Million
6,800 Added 27.09%
31,900 $6.23 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $2.59 Million - $3.12 Million
16,600 Added 195.29%
25,100 $4.68 Million
Q1 2021

May 14, 2021

SELL
$144.0 - $169.39 $3.72 Million - $4.37 Million
-25,800 Reduced 75.22%
8,500 $1.34 Million
Q4 2020

Feb 25, 2021

SELL
$157.07 - $174.35 $298,433 - $331,265
-1,900 Reduced 5.25%
34,300 $5.68 Million
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $4.73 Million - $5.71 Million
34,500 Added 2029.41%
36,200 $6.02 Million
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $5.85 Million - $7.45 Million
-52,300 Reduced 96.85%
1,700 $233,000
Q1 2020

May 15, 2020

SELL
$92.66 - $144.94 $3.25 Million - $5.09 Million
-35,100 Reduced 39.39%
54,000 $6.48 Million
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $162,750 - $186,550
-1,400 Reduced 1.55%
89,100 $11.8 Million
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $7.4 Million - $8.44 Million
65,700 Added 264.92%
90,500 $11.3 Million
Q2 2019

Aug 13, 2019

SELL
$97.98 - $114.28 $2.61 Million - $3.04 Million
-26,600 Reduced 51.75%
24,800 $2.82 Million
Q2 2018

Aug 10, 2018

SELL
$79.9 - $89.2 $3.33 Million - $3.72 Million
-41,700 Reduced 44.79%
51,400 $4.38 Million
Q1 2018

May 11, 2018

BUY
$71.51 - $84.69 $1.29 Million - $1.53 Million
18,100 Added 24.13%
93,100 $7.78 Million
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $4.48 Million - $4.91 Million
75,000
75,000 $4.78 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.